Merrimack Pharmaceuticals Inc
MACKDelisted May 10, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001274792
Merrimack Pharmaceuticals Inc was delisted on May 10, 2024; its insiders filed their last Form 4 on Dec 28, 2023; 70 institutions reported holding it in 13F filings for Q1 2024, worth $137.1M in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding Merrimack Pharmaceuticals Inc changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 37 | 40 | +3 |
| Shares | 7.50M | 7.90M | +407.0K (+5.4%) |
| Value | $29.3M | $49.4M | +$20.1M (+68.4%) |
New holders (4)
Institutions that held Merrimack Pharmaceuticals Inc at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Simplex Trading, LLC | 37,819 | $239.0K | 0.01% |
| Group One Trading, L.P. | 10,586 | $67.0K | 0.00% |
| Kayne Anderson Rudnick Investment Management LLC | 300 | $2.00K | 0.00% |
| Cubist Systematic Strategies, LLC | 368 | $2.00K | 0.00% |
Sold out (1)
Institutions that held Merrimack Pharmaceuticals Inc at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Renaissance Technologies LLC | 19,461 | $76.0K |